Cite

HARVARD Citation

    Meshram, H. et al. (2021). Feasibility and safety of remdesivir in SARS‐CoV2 infected renal transplant recipients: A retrospective cohort from a developing nation. Transplant infectious disease. 23 (4), p. n/a. [Online]. 
  
Back to record